Research ArticleConference Proceeding
Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
Junfen Ma and David Roush
PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
Junfen Ma
1Principal Scientist, Amgen Inc., Process Development, 360 Binney Street, Cambridge, MA 02142; (617) 444-5664; ; and
David Roush
2Distinguished Scientist, Merck, Sharp, and Dohme, Vaccines and Biologics, 2015 Galloping Hill Road, Mailstop K15-2-H206, Kenilworth, NJ 07033; (908) 740-3204;

References
- 1.↵
- Quertinmont M.
- 2.↵
- 3.↵
- Durno L.,
- Tounekti O.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 5
September/October 2016
Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
Junfen Ma, David Roush
PDA Journal of Pharmaceutical Science and Technology Sep 2016, 70 (5) 410-416; DOI: 10.5731/pdajpst.2016.006890
Jump to section
- Article
- Background
- A Historical Review of Low-pH Inactivation Data at Biogen (Lynn Conley and Brad Stanley; Biogen)
- Xenotropic Murine Leukemia Virus (XMuLV) Inactivation
- Suid Herpes Virus 1 (SuHV-1) Inactivation
- Generic Conditions for Triton X-100 Viral Inactivation (Julia Bach; Amgen)
- Lauryldimethylamine N-oxide (LDAO) Viral Inactivation Robustness Studies (Lynn Conley, Alexis Henry, Edward Koepf, Brad Stanley, Marisa Labanca; Biogen)
- Summary
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.